127 related articles for article (PubMed ID: 34279697)
21. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.
Chen Y; Lu Z; Zhao J; Zou Z; Gong Y; Qu F; Bao Z; Qiu G; Song M; Zhang Q; Liu L; Hu M; Han X; Tian S; Zhao J; Chen F; Zhang C; Sun Y; Verweij PE; Huang L; Han L
Antimicrob Agents Chemother; 2016 Oct; 60(10):5878-84. PubMed ID: 27431231
[TBL] [Abstract][Full Text] [Related]
22. Environmental Hotspots for Azole Resistance Selection of Aspergillus fumigatus, the Netherlands.
Schoustra SE; Debets AJM; Rijs AJMM; Zhang J; Snelders E; Leendertse PC; Melchers WJG; Rietveld AG; Zwaan BJ; Verweij PE
Emerg Infect Dis; 2019 Jul; 25(7):1347-1353. PubMed ID: 31211684
[TBL] [Abstract][Full Text] [Related]
23. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.
Jensen RH; Hagen F; Astvad KM; Tyron A; Meis JF; Arendrup MC
Clin Microbiol Infect; 2016 Jun; 22(6):570.e1-9. PubMed ID: 27091095
[TBL] [Abstract][Full Text] [Related]
24. Azole Resistance in
Guegan H; Prat E; Robert-Gangneux F; Gangneux JP
Front Cell Infect Microbiol; 2020; 10():613774. PubMed ID: 33680981
[TBL] [Abstract][Full Text] [Related]
25. Azole-resistant Aspergillus fumigatus isolates carrying TR₃₄/L98H mutations in Taiwan.
Wu CJ; Wang HC; Lee JC; Lo HJ; Dai CT; Chou PH; Ko WC; Chen YC
Mycoses; 2015 Sep; 58(9):544-9. PubMed ID: 26214171
[TBL] [Abstract][Full Text] [Related]
26. Azole-resistant Aspergillus fumigatus as an emerging worldwide pathogen.
Rivelli Zea SM; Toyotome T
Microbiol Immunol; 2022 Mar; 66(3):135-144. PubMed ID: 34870333
[TBL] [Abstract][Full Text] [Related]
27. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran.
Falahatinejad M; Vaezi A; Fakhim H; Abastabar M; Shokohi T; Zahedi N; Ansari S; Meis JF; Badali H
Mycoses; 2018 Feb; 61(2):143-147. PubMed ID: 29064130
[TBL] [Abstract][Full Text] [Related]
28. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
29. The Aspergillus fumigatus Mismatch Repair
Dos Reis TF; Silva LP; de Castro PA; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Lind AL; Rokas A; Goldman GH
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391280
[TBL] [Abstract][Full Text] [Related]
30. Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan.
Tsuchido Y; Tanaka M; Nakano S; Yamamoto M; Matsumura Y; Nagao M
Med Mycol; 2019 Nov; 57(8):997-1003. PubMed ID: 30690480
[TBL] [Abstract][Full Text] [Related]
31. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
[TBL] [Abstract][Full Text] [Related]
32. Azole resistance in Aspergillus fumigatus: a growing public health concern.
Vermeulen E; Lagrou K; Verweij PE
Curr Opin Infect Dis; 2013 Dec; 26(6):493-500. PubMed ID: 24126719
[TBL] [Abstract][Full Text] [Related]
33. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.
Meis JF; Chowdhary A; Rhodes JL; Fisher MC; Verweij PE
Philos Trans R Soc Lond B Biol Sci; 2016 Dec; 371(1709):. PubMed ID: 28080986
[TBL] [Abstract][Full Text] [Related]
35. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
36. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A; Sharma C; Hagen F; Meis JF
Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
[TBL] [Abstract][Full Text] [Related]
37. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
Riat A; Plojoux J; Gindro K; Schrenzel J; Sanglard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437612
[No Abstract] [Full Text] [Related]
38. The Multi-Fungicide Resistance Status of
Fraaije B; Atkins S; Hanley S; Macdonald A; Lucas J
Front Microbiol; 2020; 11():599233. PubMed ID: 33384673
[TBL] [Abstract][Full Text] [Related]
39. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned?
Vaezi A; Fakhim H; Javidnia J; Khodavaisy S; Abtahian Z; Vojoodi M; Nourbakhsh F; Badali H
J Mycol Med; 2018 Mar; 28(1):59-64. PubMed ID: 29496370
[TBL] [Abstract][Full Text] [Related]
40. Azole-resistant Aspergillus fumigatus in the Italian environment.
Prigitano A; Esposto MC; Romanò L; Auxilia F; Tortorano AM
J Glob Antimicrob Resist; 2019 Mar; 16():220-224. PubMed ID: 30367993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
